VanEck Biotech ETF (BBH) is a VanEck ETF with a 0.35% expense ratio, 25 holdings and $486MM in net assets. Largest sector: Healthcare (100%).
Fee
0.35%
expense ratio
Net assets
$486MM
Launched
Dec 20, 2011
Holdings
25
as of Oct 22, 2026
Top 10 weight
72.7%
largest ten holdings
Largest sector
Healthcare
100.0%
Yield
30-day SEC 0.35%
as of Oct 18, 2026
Benchmark
MVIS US Listed Biotech 25 Index
BBH's holdings are as of Oct 22, 2026.
Healthcare
100.0%
1
AMGN
AMGEN
16.48%
2
GILD
GILEAD SCIENCES
13.68%
3
VRTX
VERTEX PHARMACEUTICALS
8.28%
4
REGN
REGENERON PHARMACEUTICALS
6.91%
5
MRNA
MODERNA
6.28%
6
NTRA
Natera
4.71%
7
IQV
IQVIA
4.55%
8
ARGX
ARGENX
4.12%
9
ILMN
ILLUMINA
3.92%
10
RVMD
Revolution Medicines
3.80%
11
BIIB
BIOGEN
3.02%
12
ONC
BEONE MEDICINES LTD-ADR
2.84%
13
GH
Guardant Health
2.71%
14
ALNY
Alnylam Pharmaceuticals
2.45%
15
UTHR
United Therapeutics
2.38%
16
INCY
INCYTE
2.11%
17
INSM
Insmed
1.73%
18
CRL
CHARLES RIVER LABORATORIES
1.70%
19
BNTX
Biontech Se
1.43%
20
NBIX
Neurocrine Biosciences
1.38%
21
ICLR
ICON INVESTMENTS SIX DAC 144A
1.34%
22
TECH
BIO TECHNE
1.15%
23
QIA
QIAGEN NV
1.05%
24
BMRN
BioMarin Pharmaceutical
1.04%
25
TEM
Tempus AI Class A
0.85%
1–25 of 25
Funds listed by how much of their largest holdings they share with BBH — not a ranking.
Data from VanEck; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.